Equites Radar

SYK · Stryker Corporation

Medical DevicesUnited StatesAnalyst view: Buy

$330.25

+2.93% last session

End-of-day data · updated 2026-07-28

Mildly bullish3 bullish · 1 bearish technical signals
Consensus: Buy (1.63 from 25 analysts)
To mean target: +17.0%

Market cap

$129B

Enterprise value

$139B

Trailing P/E

38.9

Forward P/E

20.1

Dividend yield

1.0%

Beta

0.78

Avg volume

3M

Employees

56K

2D change

1.97%

5D change

5.57%

10D change

5.27%

30D change

1.48%

60D change

10.67%

MTD change

7.45%

YTD change

-3.68%

Analyst Outlook

Consensus ratingBuy
Recommendation mean (1–5)1.63
Covering analysts25
Mean price target$386.52
Low price target$315.00
Upside to mean target+17.0%

Analyst estimates change daily — follow the shifts on the Estimate Trends page.

Technical Analysis

RSI (14)63.0
50-day MA$314.42
200-day MA$342.09
Price vs 50-day MA+10.2%
Price vs 200-day MA+1.3%
MACD histogram1.30
Volume vs 3-month avg0.9×
52w low $281.8352w high $399.46

Analyst sentiment over time — SYK

Rec Mean (blue, left — higher = more bullish) vs. price targets (right).

Investment Bank Ratings as of 2026-07-09

Latest call per bank · past 12 months

Barclays

Overweight

$394

+19.3% vs price
▼ cut from $469Maintains · 2026-05-04

JP Morgan

Overweight

$400

+21.1% vs price
▼ cut from $445Maintains · 2026-05-01

Wells Fargo

Overweight

$418

+26.6% vs price
▼ cut from $456Maintains · 2026-05-01

Goldman Sachs

Neutral

$357

+8.1% vs price
▼ cut from $403Maintains · 2026-04-09

Citigroup

Buy

$385

+16.6% vs price
▼ cut from $420Maintains · 2026-04-07

UBS

Neutral

$380

+15.1% vs price
▼ cut from $400Maintains · 2026-03-17

Recent rating actions

DateFirmActionRatingPrice target
2026-07-09BMO CapitalInitiatesMarket PerformOutperform$0.00 $369
2026-07-06Evercore ISI GroupMaintainsOutperform$355 $350
2026-06-05Leerink PartnersMaintainsOutperform$410 $407
2026-05-04Truist SecuritiesReiteratesHold$380 $330
2026-05-04BarclaysMaintainsOverweight$469 $394
2026-05-01Canaccord GenuityMaintainsBuy$435 $400
2026-05-01JP MorganMaintainsOverweight$445 $400
2026-05-01Evercore ISI GroupMaintainsOutperform$365 $355

Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.

Signal Summary as of 2026-07-28

  • RSI (14): RSI is 63 — neutral momentum, neither overbought nor oversold.
  • Price vs 50-day MA: Trading 10.2% above the 50-day MA ($314.42).
  • Price vs 200-day MA: Trading 1.3% above the 200-day MA ($342.09).
  • MA cross: The 50-day MA sits below the 200-day MA (death-cross regime) — the longer-term trend points down.
  • MACD (12,26,9): MACD histogram is positive (+1.30) — short-term momentum is improving.
  • 52-week range: Price sits between the 52-week low ($281.83) and high ($399.46).

SYK Price Chart

Loading chart for SYK

Fundamentals

Revenue (TTM)$25B
EBITDA$7.0B
Free cash flow$4.0B
Operating cash flow$5.0B
Book value / share$59.94
Net debt / EBITDA1.8
WACC9.0%
Revenue growth3.00%
Earnings growth14.00%

About Stryker Corporation

Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.

More in Medical Devices

Screen SYK against the full market on the Radar →

Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.